Skip to main content
. 2017 Jul 21;37(4):BSR20170181. doi: 10.1042/BSR20170181

Figure S2. Recombinant IL-6 promotes HepG2 cell invasion in a dose-dependent manner.

(A) Representative images of invading HepG2 cells that treated by different levels of recombinant IL-6. At a concentration of 100 ng, IL-6 significantly promotes the invasion of HepG2 cells. (B) The calculated number of invading cells. Data were expressed by mean ± SEM from triplicates. *P<0.05, compared to serum free medium treated control cells.

bsr-37-bsr20170181-s1.pdf (286.9KB, pdf)